Bye bye microbead plastic pollution – the new website from Naturbeads – Eos is proud to be backing their growth
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
Eos portfolio company, Cumulus Oncology is the first oncology drug development accelerator in Europe.
Andrew Durkie has joined Eos as a Partner alongside Andy Lothian and Sandy Kennedy as Growth Advisors as we work to support our portfolio of high impact companie